Table 2.

Baseline characteristics of study cohort

Characteristic	Cohort (n = 118)
Age [years], median [IQR]	72 [65–76]
Gleason score ≥ 8 (n, %)a	67 (69.8%)
PSA [ng/ml] at 1st cycle, median [IQR]b	82.0 [23.4–266.5]
Lymphatic metastases (n, %)	68 (57.6)
Osseous metastases (n, %)	101 (85.6)
Visceral metastases (n, %)	29 (24.6)
Hb [g/dl], median [IQR]c	12.2 [10.2–13.3]
mGPSd
− 0 (n, %)	55 (57.9)
− 1 (n, %)	13 (13.7)
− 2 (n, %)	27 (28.4)
NLR, median [IQR]e	3.9 [2.74–5.82]
PLR, median [IQR]e	233.5 [141.5–312.4]
SII, median [IQR]f	160 [114.6–202.8]
AP [U/l], median [IQR]g	111.5 [74.8–230.0]
Albumin [g/dl], median [IQR]e	35.6 [31.8–38.7]
CRP [mg/l], median [IQR]h	15.4 [7.2–53.9]

^aData of 22 patient missing

^bData of 9 patients missing

^cData of 3 patients missing

^dData of 23 patients missing

^eData of 21 patients missing

^fData of 34 patients missing

^gData of 12 patients missing

^hData of 38 patients missing